Obesity & Pregnancy: Factors Influencing Participation in a Physical Activity and Nutritional Counseling Program (OGAN)

February 19, 2019 updated by: University Hospital, Lille

Obesity and Pregnancy : Study of Factors Influencing Participation in a Program Combining Physical Activity and Nutritional Counseling

Background:

Obesity increasingly affects young women and contributes to increased maternal, fetal and neonatal complications. Maternal obesity contributes to the subsequent development of childhood obesity not only through social and environmental mechanisms but also through biological processes referring to the original concept of the developmental health and disease. Data suggest that management during pregnancy through nutrition counseling and adequate physical activity will help to break the familial vicious circle of obesity. To help program to be effective it is important to understand the factors that modulate participation. However, few studies have been conducted to assess the determinants that influence participation.

Goal:

The main objective is to analyze 15 factors that influence participation in a program combining physical activity and nutritional counseling among pregnant women with BMI ≥ 25 kg/m2. Secondary objectives are :

  • to identify the data that influence adherence and to show that assiduous women will have a better control of weight gain and a reduction of maternal and fetal complications.
  • to understand the biological mechanisms involved

Strategy and method:

A prospective research evaluating the participation in an educational program, including nutritional support and adequate physical activity, will be offered to overweight and obese pregnant women. The program will last 12 weeks, and will include three workshops on diet of the pregnant and lactating women, and the young child. Physical activity sessions will be offered once a week. Fifteen independent variables likely to influence participation will be analyzed. The association between participation and the risk of maternal and fetal pregnancy complications related to obesity will be analysed. Meanwhile, more fundamental research will be considered to determine of the biological factors involved.

Study Overview

Status

Terminated

Detailed Description

This is a prospective study that will be conducted in pregnant women with a BMI ≥ 25 kg/m2, aged from 18 to 42 years. Participation in the program will be offered between 12 and 22 + 6 weeks of pregnancy. Women with a history of more than 2 miscarriages, severe heart disease (arrhythmia, previous myocardial infarction), bleeding in the first trimester, multiple pregnancy, unstable thyroid disease, hypertension, diabetes, or any other medical conditions that can interfere with the practice of physical activity during pregnancy will not be allowed to participate in the program for medical reasons. The participants will sign an informed consent. The intervention will be an educational program called "Eat well, move well for to the baby's health," including nutritional counselling and physical activity exercises. The control group will receive usual care as a simple information. The intervention will take place between 24 and 36 weeks of pregnancy. Women will be evaluated before (20-24 weeks gestation (SA)), during the intervention (32-34 SA), and finally 8 weeks after childbirth during the postnatal visit. All patients with benefit from obstetric monitoring according with the French recommendations with a monthly consultation and ultrasonography exams at 22 and 32 wks.

Nutritional support will include 3 workshops of 2 hours within the 12 weeks (one workshop per month). Each workshop session will be conducted in groups of 10 to 15 participants. These workshops will aim firstly to inform patients of weight gain recommendations during pregnancy and food recommendations.

Workshop No. 1 will provide information on the goals of weight gain during pregnancy, and will target the implementation of recommendations in terms of diet during pregnancy. The messages will be specifically adapted to the population of obese women including dietary advices, work on erroneous beliefs and representations, work on the motivation to change eating habits and reduction of the harmful link between emotions and eating. Thus, beyond the information, this workshop will have the primary role to develop a diet suitable for pregnancy in obese women. This workshop will be led by a dietician and psychologist. It will take place between the 1st and 4th week of the program.

Workshop No. 2 will inform the benefits of breastfeeding for the child and the mother (including its impact on weight loss during the postpartum period, especially important in obese women). As in the previous workshop, the objective will be to obtain the application of the recommendations on diet during breastfeeding. The general message will be adapted to the problems specific to obese women: work on the social, educational, family, removal of beliefs and motivational brakes. This workshop will be led by a dietician and a midwife and will take place between the 5th and 8th week of the program.

Workshop No. 3 will target the diet in the postpartum period and nutritional needs of the newborn and young child. Beyond dietary information, specific work will be done on motivation to take care of the body after pregnancy and breastfeeding, and especially the fight against the beliefs of the food needs of the newborn, typically found in obese mothers (fear of missing, hunger equated with suffering, the emotional power as substitute) This workshop will take place between the 9th and 12th week of the program and will be led by a dietician and a pediatric nurse.

The exercise program will feature sessions developed by the North Committee of the French Federation of Physical Education and Voluntary Gymnastics. On the program, which lasts 12 weeks per patient, there will be inputs and outputs permanent in the group based on inclusions. The program will be continued for the duration of the research. This program will propose 3 weekly slots of physical activities so that participants can take at least a weekly session. Ideally they will be encouraged to practice a second session and to perform exercises by their own. The personal session can be a walk on the weekend, or an indoor gym classes in one a club, an aqua fit session ... or exercises proposed by the coach to replicate at home. The participants will be able to record and monitor their practice using the logbook.

Evaluation of the program "Eat well, move well for the baby's health" The investigators will do the assessment before during and after the program. Patients will have a logbook in which they will notice physical activity performed. This book will include questionnaires to complete.

  1. Food Evaluation The investigators will use a food behavior questionnaire (18 items) and 5 direct questions for a semi-quantitative assessment (sweet beverages consumption, fat, portion sizes). All these elements for assessing eating behavior (uncontrolled eating, hunger, cognitive restriction), the type of food consumed (carbohydrates, fats and proteins). The evaluation will be conducted by dieticians.
  2. Evaluation of physical activity Physical activity of patients will be estimated using the French Physical Activity Questionnaire in Pregnancy (QFAPG). This self administered questionnaire will have a qualitative vision (business type) and quantitative activity through 33 questions on "sports" on "household activities " on "activities at work " and also on "activities related to transportation".

    Physical activity will be quantitatively measured for each patient who will receive an accelerometer (The Actigraph, Manufacturing Technology Inc., model wActisleep +, Pensacola, Florida USA) that will record the intensity of the efforts made during a period of 7 days.

  3. Well-being Evaluation Well-being will be evaluated using the positive and negative affect schedule Questionnaire. which is sensitive to changes over time and assesses the positive and negative affects. It will assess the program's impact on the positive / negative affect.

Study Type

Interventional

Enrollment (Actual)

195

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lille, France
        • CHRU,Hôpital Jeanne de Flandres

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion criteria :

  • Overweight and obese pregnant women
  • Age from 18 to 45 years old
  • Singleton pregnancy between 12+0 to 22+6 weeks of pregnancy

Exclusion criteria:

  • History of more than 2 miscarriages
  • Severe heart disease (arrhythmias, history of myocardial infarction)
  • Multiple pregnancy
  • Unstable thyroid disease
  • Uncontrolled hypertension
  • Pre-gestational diabetes
  • Bariatric surgery
  • Any medical condition that may interfere with physical activity during pregnancy
  • Minor or absence of health insurance
  • Trusteeship or tutorship
  • Refusal to participate in research

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: participant
agree to participate to the program combining physical activity and nutritional counseling
The program will last 12 weeks, and will include three workshops on diet of the pregnant and lactating women, and the young child. Physical activity sessions will be offered once a week.
No Intervention: no participant
disagree to participate to the program

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of participant that will participate to the program
Time Frame: at 36 weeks of gestation (WG)
at 36 weeks of gestation (WG)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Macrosomia / Birth weight
Time Frame: at birth
at birth
Gestational weight gain
Time Frame: at birth
at birth
Pregnancy complications
Time Frame: between 28 weeks of gestation and term
Gestational diabetes, gravidic hypertension and preeclampsia
between 28 weeks of gestation and term
Number of patients with C-section or an instrumental extraction
Time Frame: at birth
C-section vaginal delivery, instrumental extraction
at birth
eating behavior before, during and after the program
Time Frame: between 20-24 weeks of gestation, between 32 and 34 weeks of gestation, within 6-8 weeks post-partum
Three eating factors questionnaire / semi-qualitative questionnaire
between 20-24 weeks of gestation, between 32 and 34 weeks of gestation, within 6-8 weeks post-partum
Questionnaire of physical activity
Time Frame: between 20-24 weeks of gestation, between 32 and 34 weeks of gestation, within 6-8 weeks post-partum
french questionnaire of physical activity
between 20-24 weeks of gestation, between 32 and 34 weeks of gestation, within 6-8 weeks post-partum
Questionnaire for self-esteem
Time Frame: between 20-24 weeks of gestation, between 32 and 34 weeks of gestation, within 6-8 weeks post-partum
Positive and Negative Affect Schedule (PANAS) questionnaire
between 20-24 weeks of gestation, between 32 and 34 weeks of gestation, within 6-8 weeks post-partum
number of neonates with neonatal trauma
Time Frame: at birth
fractures, shoulder dystocia, brachial plexus injury
at birth
Apgar score
Time Frame: at birth
at birth
Arterial umbilical pH
Time Frame: at birth
at birth
number of neonates with hyperbilirubinemia
Time Frame: Within 7 days after birth
total serum bilirubin level > 86 micro mol/L
Within 7 days after birth
Number of neonates needing intensive care transfer
Time Frame: Within 7 days after birth
Within 7 days after birth
Neonatal adiposity
Time Frame: at birth
measurement of shoulder fat thickness in mm
at birth
Maternal weight
Time Frame: within 6-8 weeks post-partum
within 6-8 weeks post-partum
Infant weight
Time Frame: within 6-8 weeks post-partum
within 6-8 weeks post-partum
duration of Breastfeeding
Time Frame: within 6-8 weeks post-partum
in weeks
within 6-8 weeks post-partum
Maternal Plasmatic cholesterol levels before, during and after the program
Time Frame: between 20-24 weeks of gestation, between 32 and 34 weeks of gestation and at birth
between 20-24 weeks of gestation, between 32 and 34 weeks of gestation and at birth
Maternal Plasmatic leptin levels
Time Frame: between 20-24 weeks of gestation, between 32 and 34 weeks of gestation and at birth
between 20-24 weeks of gestation, between 32 and 34 weeks of gestation and at birth
maternal plasmatic glycemic levels
Time Frame: between 20-24 weeks of gestation, between 32 and 34 weeks of gestation and at birth
between 20-24 weeks of gestation, between 32 and 34 weeks of gestation and at birth
microRNA levels in maternal milk
Time Frame: 2 or 3 days after birth
2 or 3 days after birth
Physical activity measured with accelerometers
Time Frame: between 32 and 34 Weeks of gestation and within 6-8 weeks post-partum
measurements for 1 week
between 32 and 34 Weeks of gestation and within 6-8 weeks post-partum
Maternal Plasmatic triglyceride levels before, during and after the program
Time Frame: between 20-24 weeks of gestation, between 32 and 34 weeks of gestation and at birth
between 20-24 weeks of gestation, between 32 and 34 weeks of gestation and at birth
Maternal Plasmatic Apolipoprotein levels before, during and after the program
Time Frame: between 20-24 weeks of gestation, between 32 and 34 weeks of gestation and at birth
between 20-24 weeks of gestation, between 32 and 34 weeks of gestation and at birth
Maternal plasmatic apelin levels
Time Frame: between 20-24 weeks of gestation, between 32 and 34 weeks of gestation and at birth
between 20-24 weeks of gestation, between 32 and 34 weeks of gestation and at birth
maternal plasmatic insulin levels
Time Frame: between 20-24 weeks of gestation, between 32 and 34 weeks of gestation and at birth
between 20-24 weeks of gestation, between 32 and 34 weeks of gestation and at birth
Pittsburgh Sleep Quality Index
Time Frame: during 7 days between 20-24 weeks of gestation, between 32 and 34 weeks of gestation, within 6-8 weeks post-partum
is a self-report questionnaire that assesses sleep quality over a 1-month time interval.
during 7 days between 20-24 weeks of gestation, between 32 and 34 weeks of gestation, within 6-8 weeks post-partum

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Philippe Deruelle, MD, PhD, University Hospital, Lille

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2016

Primary Completion (Actual)

October 29, 2018

Study Completion (Actual)

October 29, 2018

Study Registration Dates

First Submitted

February 25, 2016

First Submitted That Met QC Criteria

March 2, 2016

First Posted (Estimate)

March 8, 2016

Study Record Updates

Last Update Posted (Actual)

February 21, 2019

Last Update Submitted That Met QC Criteria

February 19, 2019

Last Verified

February 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 2014_72
  • 2015-A01085-44 (Other Identifier: ID-RCB number, ANSM)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on physical activity and nutritional counseling

3
Subscribe